It seems that we have increasingly been seeing younger patients with breast and rectal cancers. What rates of radiation-caused secondary malignancy do you typically quote to your young breast or GI patients? Do the numbers differ depending on body site you are treating or age (e.g. <40 vs. >50 or 60)?
What about patients who are active tobacco users? ...